OM:VITRBiotechs
The Bull Case For Vitrolife (OM:VITR) Could Change Following Heavy Losses And An Unchanged Dividend
In early February 2026, Vitrolife AB (publ) reported fourth quarter 2025 sales of SEK 891 million and a net loss of SEK 5,314 million, while full-year 2025 sales fell to SEK 3,440 million with a net loss of SEK 5,012 million, compared with profits in the prior year.
Despite the sharp swing to losses, Vitrolife’s Board plans to propose an unchanged dividend of SEK 1.10 per share for 2025, implying a SEK 149 million payout even as earnings turned deeply negative.
We’ll now examine how this...